Mortality in Levodopa-Treated Parkinson's Disease
Parkinson's disease (PD) is associated with increased mortality despite many advances in treatment. Following the introduction of levodopa in the late 1960's, many studies reported improved or normalized mortality rates in PD. Despite the remarkable symptomatic benefits provided by levodop...
Main Authors: | Morgan, John C., Currie, Lillian J., Harrison, Madaline B., Bennett, James P., Trugman, Joel M., Wooten, G. Frederick |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927757/ |
Similar Items
-
Comparison of Endothelial Progenitor Cells in Parkinson's Disease Patients Treated with Levodopa and Levodopa/COMT Inhibitor
by: Lee, Phil Hyu, et al.
Published: (2011) -
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off
by: Kuoppamäki, Mikko, et al.
Published: (2015) -
Modulation of Habit Formation by Levodopa in Parkinson's Disease
by: Marzinzik, Frank, et al.
Published: (2011) -
Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
by: Antonini, Angelo
Published: (2009) -
Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
by: Bargiotas, Panagiotis, et al.
Published: (2013)